Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
15.77
+0.43 (2.80%)
Feb 4, 2026, 3:04 PM CST
SHE:300452 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 129.56 | 119.42 | 161.54 | 130.71 | 89.25 | 93.94 |
Depreciation & Amortization | 50.69 | 50.69 | 38.78 | 36.06 | 34.68 | 31.76 |
Other Amortization | 0.48 | 0.48 | 0.28 | 0.13 | - | - |
Loss (Gain) From Sale of Assets | -0.11 | -0.11 | 0.01 | 0.27 | 0.12 | 0.55 |
Asset Writedown & Restructuring Costs | 39.13 | 39.13 | 1.02 | 0.01 | 8.97 | 1.31 |
Loss (Gain) From Sale of Investments | -16.25 | -16.25 | -19.05 | -5.11 | -7.83 | -4.2 |
Provision & Write-off of Bad Debts | -0 | -0 | 0.05 | -0.04 | -0.01 | -0.17 |
Other Operating Activities | 80.21 | 11.95 | 7.04 | -1.13 | -2.23 | 1.17 |
Change in Accounts Receivable | -96.59 | -96.59 | -42.25 | -98.58 | -28.04 | -48.23 |
Change in Inventory | 5.34 | 5.34 | -2.91 | -13.43 | -28.91 | -2.31 |
Change in Accounts Payable | -3.27 | -3.27 | -15.12 | 77.63 | 36.86 | 11.62 |
Change in Other Net Operating Assets | 0.07 | 0.07 | 0.26 | 0.9 | 3.84 | 0.43 |
Operating Cash Flow | 196.72 | 118.33 | 132.3 | 132.82 | 103.82 | 85.55 |
Operating Cash Flow Growth | 79.21% | -10.56% | -0.39% | 27.93% | 21.36% | 7.65% |
Capital Expenditures | -38.8 | -27.94 | -54.92 | -67.31 | -31.47 | -21.36 |
Sale of Property, Plant & Equipment | 0.74 | 0.55 | 0.1 | 0.69 | 0.55 | - |
Investment in Securities | 9 | -7 | -288.69 | -29.31 | 5 | -69 |
Other Investing Activities | 10.13 | 19.38 | 10.54 | 7.73 | 6.08 | 3.47 |
Investing Cash Flow | -18.93 | -15.01 | -332.98 | -88.21 | -19.84 | -86.89 |
Short-Term Debt Issued | - | 14.85 | - | 49.8 | 31.15 | 49.09 |
Long-Term Debt Issued | - | 32.22 | 338.88 | - | - | - |
Total Debt Issued | 30.87 | 47.08 | 338.88 | 49.8 | 31.15 | 49.09 |
Short-Term Debt Repaid | - | - | - | -41 | -40.1 | -20.22 |
Long-Term Debt Repaid | - | -50.52 | -49.57 | - | - | - |
Total Debt Repaid | -47.76 | -50.52 | -49.57 | -41 | -40.1 | -20.22 |
Net Debt Issued (Repaid) | -16.89 | -3.44 | 289.31 | 8.8 | -8.95 | 28.87 |
Issuance of Common Stock | - | - | - | - | - | 20.08 |
Repurchase of Common Stock | -22.51 | -22.51 | - | - | - | - |
Common Dividends Paid | -66.96 | -59.01 | -59.78 | -55.33 | -46.32 | -35.07 |
Other Financing Activities | 22.26 | -0.25 | -1.36 | -1.99 | - | -5.12 |
Financing Cash Flow | -84.09 | -85.21 | 228.17 | -48.52 | -55.27 | 8.76 |
Foreign Exchange Rate Adjustments | 1.03 | 1.22 | -0.01 | 2.56 | -0.28 | -1 |
Net Cash Flow | 94.72 | 19.33 | 27.47 | -1.35 | 28.43 | 6.42 |
Free Cash Flow | 157.92 | 90.39 | 77.38 | 65.5 | 72.35 | 64.19 |
Free Cash Flow Growth | 92.17% | 16.82% | 18.13% | -9.46% | 12.71% | 226.94% |
Free Cash Flow Margin | 16.89% | 10.24% | 9.22% | 9.30% | 11.73% | 12.08% |
Free Cash Flow Per Share | 0.66 | 0.39 | 0.32 | 0.28 | 0.31 | 0.28 |
Cash Income Tax Paid | 58.06 | 58.72 | 15.47 | 40.46 | 40.42 | 38.13 |
Levered Free Cash Flow | 132.24 | 25.89 | 53.49 | 114.88 | 45.79 | 41.73 |
Unlevered Free Cash Flow | 140.03 | 33.85 | 56.18 | 115.64 | 46.54 | 42.19 |
Change in Working Capital | -86.99 | -86.99 | -57.37 | -28.09 | -19.13 | -38.82 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.